A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)Xingsheng Hu, Yan Sun, Shun Chang Jiao et al.|Lung Cancer|2014Cited by 51
Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study.Fenlai Tan, Yan Sun, Aiqin Gu et al.|Journal of Clinical Oncology|2013Cited by 5
Knockdown of GBAS regulates esophageal cancer cell viability and apoptosisJun Peng, Jintao He|Molecular Medicine Reports|2021Cited by 1